<i>Eubacterium limosum</i> modulates gut microbiota and produces anti-inflammatory metabolites to alleviate DSS-induced colitis.

Front Immunol · 2025 · PMC12747957 · PMID 41476955

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

an increasing trendno p-value reported

Compared with the NC group, the Firmicutes/Bacteroidota (F/B) ratio of the DSS group showed an increasing trend; compared with the DSS group, the F/B ratio of the El1405 group showed a decreasing trend.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.